mRNA肿瘤疫苗的重磅节点,可能近了。3月5日,Moderna在投资者会议上表示,该公司有望于2027年推出首个mRNA肿瘤疫苗V940。安进继续押注减肥药。3月5日,据全球临床试验收录网站clinicaltrials,安进启动了AMG 133的两项减重III期临床试验,标志着AMG 133进入III期开发阶段。京东健康发布成绩单,营收、利润增速均低于10%3月6日,京东健康发布2024年全年业绩...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.